09
/
23
/
21
A Commercial Accelerator: Generative AI's Most Immediate Impact on BioPharma

Speaker Name

Job Title

Company Name

Reuters Events
A Commercial Accelerator: Generative AI's Most Immediate Impact on BioPharma
September 
21
, 
2023
 / 
11am
 
EDT
 / 4pm BST / 5pm CET
Dreamfield logo

SPONSORED BY

ReutersEventsLogo

Speaker Highlights

Moderator:

Teja Ream

Executive Director Global Content

Amgen

Vyom Bhuta

global head of commercial innovation, life sciences

cognizant

Leo Barella

SVP,

Chief Technology Officer

Takeda

Jason O’Meara

Vice President,

Digital Strategic Initiatives

Pfizer

Florent Edouard

SVP,

Global Head of Commercial Excellence

Grünenthal Group

In today's fast-moving market, the evolution of artificial intelligence (AI) is presenting unprecedented opportunities in life sciences to streamline processes, enhance engagement, and accelerate growth.

Conventional AI detects a pattern and produces an output. Generative AI continually evolves an output through language. For life sciences, this opens up all sorts of opportunities across each stage of bringing a therapy to market -- whether that's reviewing research, designing a clinical trial or preparing data for regulatory submission and approval. The most immediate impact, however, could be found within a life sciences organization's commercial function. Roles within sales and marketing are ripe for augmentation and transformation due to the ability of large language models (LLMs) to dynamically generate content. 


In this webinar, industry experts will provide a comprehensive overview of generative AI's impact on sales and marketing functions and discuss how these innovations can be leveraged to stay ahead in this competitive market.


Panelists will share their perspectives on:


  • Practical use cases that life sciences commercial teams can adopt to harness the full potential of generative AI in key areas, including customer care, marketing operations, sales force effectiveness, and creative and product design.
  • Future trends in the AI-driven pharmaceutical landscape, such as bionic sales forces and personalized at-home patient care.
  • Ethical implications and regulatory challenges around implementing generative AI technologies in life sciences and strategies for responsible AI adoption.


Don't miss the opportunity to engage with industry experts and be at the forefront of the transformative AI revolution in the pharmaceutical sector. 

REGISTER NOW
Text goes here
X

© 2021 REUTERS. ALL RIGHTS RESERVED.

[confirmation_headline]
[confirmation_messaging]

Webinar available on Demand, please use the button below to access the recording

Access Recording
Text goes here
X

If you're interested in this, make sure you check out our conference which will explore similar opportunities and challenges

VIEW EVENT
Text goes here
X
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
Share with Friends
Facebook
Twitter
LinkedIn
Link
CONTACT THE ORGANIZER
Google   Outlook   iCal   Yahoo

RSVP

Google Icon
Google
Outlook Icon
Outlook
Apple Icon
Apple
Yahoo Icon
Yahoo